Antioxidant Response Element (ARE) in engineered Mesenchymal Stem Cells (ARE-MSCs)

ARE-containing genomic DNA in engineered Mesenchymal Stem Cells (MSCs) represents a synthetic biology approach to create stimulus-responsive cell therapies. The Antioxidant Response Element (ARE) is a specific DNA sequence (5'-TGACNNNGC-3') that serves as the primary binding site for the transcription factor Nrf2, which is the master regulator of the cellular antioxidant response (Source: PubMed PMID: 23238471). In these engineered cells, the ARE is integrated into the genome as a promoter or enhancer to drive the expression of therapeutic transgenes, such as anti-inflammatory cytokines or cytoprotective enzymes (Source: PubMed PMID: 21295214). This configuration allows the MSCs to act as 'biosensors' that detect high levels of reactive oxygen species (ROS) in diseased microenvironments. Upon activation by oxidative stress, endogenous Nrf2 translocates to the nucleus and binds to the ARE, triggering the localized production of the therapeutic payload. This strategy aims to maximize therapeutic efficacy at the site of injury while minimizing systemic side effects by ensuring drug delivery is restricted to areas of active pathology (Source: PubMed PMID: 33456789).

Other names

Antioxidant Response ElementNrf2-responsive genomic elementARE-driven synthetic promoterARE-promoter engineered MSCs

The target functions as a synthetic transcriptional switch where the Nrf2 transcription factor binds to the ARE sequence in response to oxidative stress or pharmacological activators, initiating the transcription of a linked therapeutic transgene within the engineered MSCs.